Americans will need a REAL ID-compliant driver's license, passport or other approved federal identification document to fly on an airplane starting tomorrow. However, there are ways around it.

A spectacular 93rd-minute Fede Valverde volley gave Real Madrid victory over Athletic Club, with Los Blancos winning 1-0 at the Santiago Bernabeu. Real Madrid came into the bout knowing that three ...

The countdown is on: In less than 20 days, the REAL ID requirement will take effect, requiring Americans to obtain a new form of identification in order to fly domestically. Other identification ...

May 7, 2025, is fast approaching — the date your travel plans might just hit turbulence if you're not REAL ID-ready. In New Jersey, obtaining a REAL ID through the NJMVC can be difficult due to ...

Starting May 7, 2025, travelers aged 18 and older will need a Real ID-compliant document to fly domestically. Acceptable documents include state-issued driver's licenses or ID cards with a Real ID ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its strategic reboot. The company will henceforth be known as Whitehawk ...

The REAL ID Act will be federally enforced beginning on May 7. Do you need to make the change? The REAL ID Act, originally passed by Congress in 2005 as a response to the 9/11 terrorist attacks ...

AADI BIOSCIENCE ($AADI) is expected to release its quarterly earnings data on Wednesday, March 19th after market close, per Finnhub. Analysts are expecting revenue of ...

After years of delay, U.S. residents will need a Real ID by May 7, 2025. A Real ID is an “enhanced version” of a driver’s license of state ID card that meets federal standards, according to ...

MORRISTOWN, N.J., March 4, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to ...

Aadi Bioscience has rebooted its operations, transforming from a commercial business into a preclinical biotech by offloading its approved product and licensing antibody-drug conjugates (ADCs) for ...

LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) today announced it has entered into an exclusive license agreement for development and global commercialization of a ...